Cargando…

46 XX male syndrome with hypogonadotropic hypogonadism: A case report

We report a 46 XX male syndrome diagnosed after failure of gonadotropin therapy taken for hypogonadotropic hypogonadism due to a pituitary macroadenoma. A 39-year-old man with a non-functioning pituitary macroadenoma was admitted to our clinic due to vision loss and infertility. After pituitary surg...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalcin, Mehmet M, Ozkan, Cigdem, Akturk, Mujde, Percin, Ferda Emriye, Altinova, Alev, Karakoc, Ayhan, Ayvaz, Goksun, Cakir, Nuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790926/
https://www.ncbi.nlm.nih.gov/pubmed/31650121
http://dx.doi.org/10.14744/nci.2018.57625
_version_ 1783458873046204416
author Yalcin, Mehmet M
Ozkan, Cigdem
Akturk, Mujde
Percin, Ferda Emriye
Altinova, Alev
Karakoc, Ayhan
Ayvaz, Goksun
Cakir, Nuri
author_facet Yalcin, Mehmet M
Ozkan, Cigdem
Akturk, Mujde
Percin, Ferda Emriye
Altinova, Alev
Karakoc, Ayhan
Ayvaz, Goksun
Cakir, Nuri
author_sort Yalcin, Mehmet M
collection PubMed
description We report a 46 XX male syndrome diagnosed after failure of gonadotropin therapy taken for hypogonadotropic hypogonadism due to a pituitary macroadenoma. A 39-year-old man with a non-functioning pituitary macroadenoma was admitted to our clinic due to vision loss and infertility. After pituitary surgery, vision loss improved while infertility still existed. Low testosterone levels without elevated gonadotropins were established suggesting hypogonadotropic hypogonadism due to pituitary adenoma. Gonadotropin treatment was initiated. There was no response to treatment after 12 months. A karyotype analysis was ordered to investigate other causes of infertility. Karyotype analysis showed a 46 XX male syndrome that can explain the failure of gonadotropin therapy. Testosterone therapy was started instead of gonadotropin therapy. 46 XX male syndrome usually presents with hypergonadotropic hypogonadism. However, in our case, it presented with hypogonadotropic hypogonadism due to pituitary mass not responding to gonadotropin therapy. It is important to keep in mind to obtain a genetic analysis of patients whose gonadotropin therapy failed, even if their gonadotropin levels are not elevated.
format Online
Article
Text
id pubmed-6790926
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-67909262019-10-24 46 XX male syndrome with hypogonadotropic hypogonadism: A case report Yalcin, Mehmet M Ozkan, Cigdem Akturk, Mujde Percin, Ferda Emriye Altinova, Alev Karakoc, Ayhan Ayvaz, Goksun Cakir, Nuri North Clin Istanb Case Report We report a 46 XX male syndrome diagnosed after failure of gonadotropin therapy taken for hypogonadotropic hypogonadism due to a pituitary macroadenoma. A 39-year-old man with a non-functioning pituitary macroadenoma was admitted to our clinic due to vision loss and infertility. After pituitary surgery, vision loss improved while infertility still existed. Low testosterone levels without elevated gonadotropins were established suggesting hypogonadotropic hypogonadism due to pituitary adenoma. Gonadotropin treatment was initiated. There was no response to treatment after 12 months. A karyotype analysis was ordered to investigate other causes of infertility. Karyotype analysis showed a 46 XX male syndrome that can explain the failure of gonadotropin therapy. Testosterone therapy was started instead of gonadotropin therapy. 46 XX male syndrome usually presents with hypergonadotropic hypogonadism. However, in our case, it presented with hypogonadotropic hypogonadism due to pituitary mass not responding to gonadotropin therapy. It is important to keep in mind to obtain a genetic analysis of patients whose gonadotropin therapy failed, even if their gonadotropin levels are not elevated. Kare Publishing 2018-09-05 /pmc/articles/PMC6790926/ /pubmed/31650121 http://dx.doi.org/10.14744/nci.2018.57625 Text en Copyright: © 2019 by Istanbul Northern Anatolian Association of Public Hospitals http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Case Report
Yalcin, Mehmet M
Ozkan, Cigdem
Akturk, Mujde
Percin, Ferda Emriye
Altinova, Alev
Karakoc, Ayhan
Ayvaz, Goksun
Cakir, Nuri
46 XX male syndrome with hypogonadotropic hypogonadism: A case report
title 46 XX male syndrome with hypogonadotropic hypogonadism: A case report
title_full 46 XX male syndrome with hypogonadotropic hypogonadism: A case report
title_fullStr 46 XX male syndrome with hypogonadotropic hypogonadism: A case report
title_full_unstemmed 46 XX male syndrome with hypogonadotropic hypogonadism: A case report
title_short 46 XX male syndrome with hypogonadotropic hypogonadism: A case report
title_sort 46 xx male syndrome with hypogonadotropic hypogonadism: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790926/
https://www.ncbi.nlm.nih.gov/pubmed/31650121
http://dx.doi.org/10.14744/nci.2018.57625
work_keys_str_mv AT yalcinmehmetm 46xxmalesyndromewithhypogonadotropichypogonadismacasereport
AT ozkancigdem 46xxmalesyndromewithhypogonadotropichypogonadismacasereport
AT akturkmujde 46xxmalesyndromewithhypogonadotropichypogonadismacasereport
AT percinferdaemriye 46xxmalesyndromewithhypogonadotropichypogonadismacasereport
AT altinovaalev 46xxmalesyndromewithhypogonadotropichypogonadismacasereport
AT karakocayhan 46xxmalesyndromewithhypogonadotropichypogonadismacasereport
AT ayvazgoksun 46xxmalesyndromewithhypogonadotropichypogonadismacasereport
AT cakirnuri 46xxmalesyndromewithhypogonadotropichypogonadismacasereport